Geron (GERN) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Geron (GERN) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 15.61% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.73% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 14.05% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 11.65% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 411.50% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -3.34% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.66% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.26% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -1.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.71% |
| Mar 31, 2026 | -2.11% |
| Dec 31, 2025 | 3.69% |
| Sep 30, 2025 | 9.90% |
| Jun 30, 2025 | 22.87% |
| Mar 31, 2025 | 21.28% |
| Dec 31, 2024 | 26.31% |
| Sep 30, 2024 | 37.92% |
| Jun 30, 2024 | 40.20% |
| Mar 31, 2024 | 39.44% |
| Dec 31, 2023 | 21.39% |
| Sep 30, 2023 | 21.34% |
| Jun 30, 2023 | 16.04% |
| Mar 31, 2023 | 12.48% |
| Dec 31, 2022 | 24.80% |
| Sep 30, 2022 | 28.19% |
| Jun 30, 2022 | 85.76% |
| Mar 31, 2022 | 93.32% |
| Dec 31, 2021 | 122.51% |
| Sep 30, 2021 | 109.63% |